Insider Trading activities of Protagonist Therapeutics, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Protagonist Therapeutics, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Protagonist Therapeutics, Inc since year 2005. Table 2 shows the detailed insider transactions of Protagonist Therapeutics, Inc since 2005. The reporting company's ticker symbol is PTGX. The reporting company's CIK number is 1377121.
The total value of stock buying since 2005 is $34,999,980.
The total value of stock sales since 2005 is $795,324.
The total value of stock option exercises since 2005 is $174,033.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Protagonist Therapeutics, Inc (PTGX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 22,404 $445,402 22,404 $56,889
2017-11 0 $0 7,875 $136,262 7,000 $21,350
2017-10 0 $0 2,017 $38,323 2,017 $8,491
2017-09 0 $0 3,687 $52,753 0 $0
2017-08 0 $0 5,012 $78,204 5,012 $21,100
2017-07 0 $0 3,500 $44,380 3,500 $6,615
2017-05 0 $0 0 $0 19,099 $22,154
2017-04 0 $0 0 $0 20,000 $23,200
2017-03 0 $0 0 $0 16,362 $14,234
2016-08 2,916,665 $34,999,980 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Protagonist Therapeutics, Inc insiders (PTGX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-22 Shames Richard S. (Chief Medical Officer) Sale 3,529 20.50 72,344
2017-12-22 Shames Richard S. (Chief Medical Officer) Option Ex 3,529 4.21 14,857
2017-12-21 Patel Dinesh V Ph D (President and CEO) Sale 8,210 19.56 160,571
2017-12-21 Patel Dinesh V Ph D (President and CEO) Option Ex 8,210 1.89 15,516
2017-12-20 Patel Dinesh V Ph D (President and CEO) Sale 1,790 19.55 34,987
2017-12-20 Patel Dinesh V Ph D (President and CEO) Option Ex 1,790 1.89 3,383
2017-12-18 Liu David Y (Chief Scientific Officer) Sale 875 20.00 17,500
2017-12-18 Liu David Y (Chief Scientific Officer) Option Ex 875 1.89 1,653
2017-12-18 O'neil Thomas P. (Chief Financial Officer) Sale 8,000 20.00 160,000
2017-12-18 O'neil Thomas P. (Chief Financial Officer) Option Ex 8,000 2.69 21,480
2017-11-30 Liu David Y (Chief Scientific Officer) Sale 875 20.00 17,500
2017-11-13 Liu David Y (Chief Scientific Officer) Sale 7,000 16.97 118,762
2017-11-13 Liu David Y (Chief Scientific Officer) Option Ex 7,000 3.05 21,350
2017-10-05 Shames Richard S. (Chief Medical Officer) Sale 2,017 19.00 38,323
2017-10-05 Shames Richard S. (Chief Medical Officer) Option Ex 2,017 4.21 8,491
2017-09-12 Shames Richard S. (Chief Medical Officer) Sale 3,687 14.31 52,753
2017-08-29 Shames Richard S. (Chief Medical Officer) Sale 1,512 17.00 25,704
2017-08-29 Shames Richard S. (Chief Medical Officer) Option Ex 1,512 4.21 6,365
2017-08-28 Liu David Y (Chief Scientific Officer) Sale 3,500 15.00 52,500
2017-08-28 Liu David Y (Chief Scientific Officer) Option Ex 3,500 4.21 14,735
2017-07-10 Liu David Y (Chief Scientific Officer) Sale 3,500 12.68 44,380
2017-07-10 Liu David Y (Chief Scientific Officer) Option Ex 3,500 1.89 6,615
2017-05-09 Patel Dinesh V Ph D (President and CEO) Option Ex 19,099 1.16 22,154
2017-04-06 Patel Dinesh V Ph D (President and CEO) Option Ex 20,000 1.16 23,200
2017-03-10 Patel Dinesh V Ph D (President and CEO) Option Ex 16,362 .87 14,234
2016-08-16 Papanek Julie (Director) Buy 583,333 12.00 6,999,996
2016-08-16 Canaan Partners X Llc (Director) Buy 583,333 12.00 6,999,996
2016-08-16 Shanafelt Armen (Director) Buy 583,333 12.00 6,999,996
2016-08-16 Hall Steven Edward (10% Owner) Buy 583,333 12.00 6,999,996
2016-08-16 Johnson & Johnson Innovation - Jjdc, Inc. (10% Owner) Buy 583,333 12.00 6,999,996

Insider trading activities including stock purchases, stock sales, and option exercises of PTGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Protagonist Therapeutics, Inc (symbol PTGX, CIK number 1377121) see the Securities and Exchange Commission (SEC) website.